Evaluation of the promoter region polymorphism (5‑HTTLPR) in the serotonin transporter gene in females with postpartum depression

Zhang,Xiaoli; Wang,Lin; Huang,Fenghua; Li,Jiafu; Xiong,Li; Xue,Han; Zhang,Yuanzhen

doi:10.3892/etm.2014.2043

Evaluation of the promoter region polymorphism (5‑HTTLPR) in the serotonin transporter gene in females with postpartum depression

Authors:
- Xiaoli Zhang
- Lin Wang
- Fenghua Huang
- Jiafu Li
- Li Xiong
- Han Xue
- Yuanzhen Zhang
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China, Department of Histology and Embryology, Medical College of Wuhan University, Wuhan, Hubei 430071, P.R. China, Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China, Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: October 31, 2014 https://doi.org/10.3892/etm.2014.2043
Pages: 245-249

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the association between polymorphism in the serotonin transporter (5‑HTT) gene‑linked polymorphic region (5‑HTTLPR) in the promoter region of the 5‑HTT gene and the pathogenesis of postpartum depression (PPD). Blood samples were collected from 120 female patients with PPD and 140 age‑matched normal controls. Polymerase chain reaction analysis was performed to detect the 5‑HTTLPR polymorphism in these subjects, and the genotype and allele frequencies were compared between the two groups. The disease severity was evaluated using the Hamilton Depression Rating Scale (HAMD) score. The results showed that the frequency of the homozygous long/long (L/L) genotype was significantly lower in the PPD group than that in the control group; by contrast, the frequencies of the heterozygous long/short (L/S) and homozygous S/S genotypes were similar for the two groups, without significant differences. No significant differences were observed in the L and S allele frequencies between the two groups. Furthermore, compared with the L/S heterozygous and S/S homozygous genotypes, patients with PPD with the L/L homozygous genotype had a significantly lower HAMD score. The present results suggest that female patients with PPD carrying the homozygous L/L genotype may be less susceptible to depressive symptoms and that the L/L genotype may be associated with the reduced occurrence of PPD. These findings provide a theoretical basis for the clinical diagnosis and treatment of PPD.

View Figures

View References

1	O’Hara MW and McCabe JE: Postpartum depression: current status and future directions. Annu Rev Clin Psychol. 9:379–407. 2013. View Article : Google Scholar
2	Paulson JF and Bazemore SD: Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA. 303:1961–1969. 2010. View Article : Google Scholar : PubMed/NCBI
3	Fitelson E, Kim S, Baker AS and Leight K: Treatment of postpartum depression: clinical, psychological and pharmacological options. Int J Womens Health. 3:1–14. 2010.
4	O’Keane V, Lightman S, Patrick K, et al: Changes in the maternal hypothalamic-pituitary-adrenal axis during the early puerperium may be related to the postpartum ‘blues’. J Neuroendocrinol. 23:1149–1155. 2011. View Article : Google Scholar
5	Skalkidou A, Hellgren C, Comasco E, Sylvén S and Sundström Poromaa I: Biological aspects of postpartum depression. Womens Health (LondEngl). 8:659–672. 2012. View Article : Google Scholar
6	Vliegen N, Casalin S and Luyten P: The course of postpartum depression: a review of longitudinal studies. Harv Rev Psychiatry. 22:1–22. 2014. View Article : Google Scholar : PubMed/NCBI
7	Maes M, Ringel K, Kubera M, Berk M and Rybakowski J: Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord. 136:386–392. 2012. View Article : Google Scholar
8	Maes M, Leonard BE, Myint AM, Kubera M and Verkerk R: The new ‘5-HT’ hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 35:702–721. 2011. View Article : Google Scholar
9	Lee S, Jeong J, Kwak Y and Park SK: Depression research: where are we now? Mol Brain. 3:82010. View Article : Google Scholar : PubMed/NCBI
10	Pitychoutis PM, Dalla C, Sideris AC, Tsonis PA and Papadopoulou-Daifoti Z: 5-HT(1A), 5-HT(2A), and 5-HT(2C) receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: sex differences exposed. Neuroscience. 210:152–167. 2012. View Article : Google Scholar : PubMed/NCBI
11	Stephens MA, McCaul ME, Weerts EM and Wand G: Serotonin transporter-linked polymorphic region (5-HTTLPR) genotype is associated with cortisol responsivity to naloxone challenge. Psychopharmacology (Berl). 224:223–230. 2012. View Article : Google Scholar
12	Heils A, Teufel A, Petri S, et al: Allelic variation of human serotonin transporter gene expression. J Neurochem. 66:2621–2624. 1996. View Article : Google Scholar : PubMed/NCBI
13	Dai Y, Yu X, Xiao Z, et al: Comparison of Chinese and international psychiatrists’ views on classification of mental disorders. Asia Pac Psychiatry. 6:267–273. 2014. View Article : Google Scholar : PubMed/NCBI
14	Zimmermann-Peruzatto JM, Almeida S, Lucion AB, et al: Evaluation of the 5-HTTLPR and 5 -HTTVNTR polymorphisms in the serotonin transporter gene in women with postpartum depression. Neurosci Med. 3:275–280. 2012. View Article : Google Scholar
15	Pitt B: “Atypical” depression following childbirth”. Br J Psychiatry. 114:1325–1335. 1968. View Article : Google Scholar : PubMed/NCBI
16	Mohammed ES, Mosalem FA, Mahfouz EM and Abd ElHameed MA: Predictors of postpartum depression among rural women in Minia, Egypt: an epidemiological study. Public Health. 128:817–824. 2014. View Article : Google Scholar : PubMed/NCBI
17	Ayuso-Mateos JL, Vázquez-Barquero JL, Dowrick C, et al: Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry. 179:308–316. 2001. View Article : Google Scholar : PubMed/NCBI
18	Bener A, Burgut FT, Ghuloum S and Sheikh J: A study of postpartum depression in a fast developing country: prevalence and related factors. Int J Psychiatry. 43:325–337. 2012. View Article : Google Scholar
19	Mitchell C, Notterman D, Brooks-Gunn J, et al: Role of mother’s genes and environment in postpartum depression. Proc Natl Acad Sci USA. 108:8189–8193. 2011. View Article : Google Scholar
20	Pinheiro RT, Coelho FM, Silva RA, et al: Association of a serotonin transporter gene polymorphism (5-HTTLPR) and stressful life events with postpartum depressive symptoms: a population-based study. J Psychosom Obstet Gynaecol. 34:29–33. 2013. View Article : Google Scholar : PubMed/NCBI
21	Kuzelova H, Ptacek R and Macek M: The serotonin transporter gene (5-HTT) variant and psychiatric disorders: review of current literature. Neuro Endocrinol Lett. 31:4–10. 2010.PubMed/NCBI
22	Domínguez-López S, Howell R and Gobbi G: Characterization of serotonin neurotransmission in knockout mice: implications for major depression. Rev Neurosci. 23:429–443. 2012.PubMed/NCBI
23	Sharp T and Cowen PJ: 5-HT and depression: is the glass half-full? Curr Opin Pharmacol. 11:45–51. 2011. View Article : Google Scholar : PubMed/NCBI
24	Landén M and Thase ME: A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT2 receptors. Psychopharmacol Bull. 39:147–166. 2006.PubMed/NCBI
25	Smeraldi E, Zanardi R, Benedetti F, et al: Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry. 3:508–511. 1998. View Article : Google Scholar : PubMed/NCBI
26	Guscott M, Bristow LJ, Hadingham K, et al: Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology. 48:492–502. 2005. View Article : Google Scholar : PubMed/NCBI
27	Watanabe MA, Nunes SO, Amarante MK, et al: Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour. J Genet. 90:179–185. 2011. View Article : Google Scholar : PubMed/NCBI
28	Hoefgen B, Schulze TG, Ohlraun S, et al: The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biological Psychiatry. 57:247–251. 2005. View Article : Google Scholar : PubMed/NCBI
29	Nobile M, Cataldo MG, Giorda R, et al: A case-control and family-based association study of the 5-HTTLPR in pediatric-onset depressive disorders. Biol Psychiatry. 56:292–295. 2004. View Article : Google Scholar : PubMed/NCBI
30	Gonda X, Juhasz G, et al: Subthreshold depression is linked to the functional polymorphism of the 5HTtransporter gene. J Affect Disord. 87:291–297. 2005. View Article : Google Scholar : PubMed/NCBI
31	Zhang K, Xu Q, Xu Y, et al: The combined effects of the 5-HTTLPR and 5-HTR1A genes modulates the relationship between negative life events and major depressive disorder in a Chinese population. J Affect Disord. 114:224–231. 2009. View Article : Google Scholar
32	Hemmati S, Kahrizi K, Najmabadi H and Sahrawian S: Analysis of association serotonin transporter gene and antidepressant response to citalopram in iranian major depressive population. European Psychiatry. 27:12012. View Article : Google Scholar
33	Cervilla JA, Molina E, Rivera M, et al; PREDICT Study Core Group. The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort. Mol Psychiatry. 12:748–755. 2007. View Article : Google Scholar : PubMed/NCBI
34	Steffens DC, Svenson I, Marchuk DA, et al: Allelic differences in the serotonin transporter-linked polymorphic region in geriatric depression. Am J Geriatr Psychiatry. 10:185–191. 2002. View Article : Google Scholar : PubMed/NCBI
35	Clarke H, Flint J, Attwood AS and Munafò MR: Association of the 5-HTTLPR genotype and unipolar depression: a meta-analysis. Psychol Med. 40:1767–1778. 2010. View Article : Google Scholar : PubMed/NCBI
36	Furlong RA, Ho L, Walsh C, et al: Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet. 81:58–63. 1998. View Article : Google Scholar : PubMed/NCBI
37	Minov C, Baghai TC, Schüle C, et al: Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett. 303:119–122. 2001. View Article : Google Scholar : PubMed/NCBI
38	Xia DS, Guo QY, Liu YQ, et al: Association of serotonin transporter gene linked polymorphic region polymorphism with early onset myocardial infarction and platelet membrane glycoprotein I b. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 26:31–34. 2009.(In Chinese). PubMed/NCBI
39	Shen Y, Li H, Gu N, et al: Relationship between suicidal behavior of psychotic inpatients and serotonin transporter gene in Han Chinese. Neurosci Lett. 372:94–98. 2004. View Article : Google Scholar : PubMed/NCBI